A critical overview of long non-coding RNA in glioma etiology 2016: an update

Tumour Biol. 2016 Nov;37(11):14403-14413. doi: 10.1007/s13277-016-5307-4. Epub 2016 Sep 15.

Abstract

With the development of whole genome and transcriptome sequencing technologies, a growing body of long non-coding RNAs (lncRNAs) has been identified and is receiving increasing attention. LncRNAs are non-protein encoding transcripts whose functions are crucial for advancing our comprehensive understanding of biological processes in human health and diseases, specifically glioma. It has been established that lncRNAs are differently expressed in the central nervous system and may play a vital role in glioma. As of June 2016, 20 lncRNAs have been identified that may play a role in glioma pathogenesis. Investigation into the role of lncRNAs in glioma may help to identify potential biomarkers which can improve the diagnosis and treatment of glioma. In this paper, we review current understanding of the function of lncRNAs in glioma initiation and progression.

Keywords: Functional roles; Glioma; Potential biomarkers and therapeutic targets; lncRNAs.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Central Nervous System / pathology*
  • Disease Progression
  • Glioma / genetics*
  • Glioma / pathology*
  • Humans
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • RNA, Long Noncoding